AI-driven identification of Zika virus inhibitors

This publication has 39 references indexed in Scilit:

• Drupacine as a potent SARS-CoV-2 replication inhibitor in vitro
  Biosafety and Health, 2024
• EBOLApred: A machine learning-based web application for predicting cell entry inhibitors of the Ebola virus
  Computational Biology and Chemistry, 2022
• Targeting non-structural proteins of Hepatitis C virus for predicting repurposed drugs using QSAR and machine learning approaches
  Computational and Structural Biotechnology Journal, 2022
• Anti-Ebola: an initiative to predict Ebola virus inhibitors through machine learning
  Molecular Diversity, 2021
• Prediction of repurposed drugs for Coronaviruses using artificial intelligence and machine learning
  Computational and Structural Biotechnology Journal, 2021
• Applications of machine learning and artificial intelligence for Covid-19 (SARS-CoV-2) pandemic: A review
  Chaos, Solitons & Fractals, 2020
• Rapid Identification of Potential Inhibitors of SARS‐CoV‐2 Main Protease by Deep Docking of 1.3 Billion Compounds
  Molecular Informatics, 2020
• Zika virus outbreak: a review of neurological complications, diagnosis, and treatment options
  Journal of NeuroVirology, 2018
• A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection
  Cell Host & Microbe, 2016
• High-content screening in infectious diseases
  Current Opinion in Chemical Biology, 2011